Activation is particularly successful in osteosarcoma patients, as osteosarcoma cells have high expression of CD54 and CD58 cell-surface molecules, allowing for easy detection and stronger binding with NK cells (34–36). This evidence concerns the gene ICAM1 and osteosarcoma.